Welcome to LookChem.com Sign In|Join Free
  • or
19-Norandrost-5(10)-ene-3,17-dione is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

3962-66-1

Post Buying Request

3962-66-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3962-66-1 Usage

Flammability and Explosibility

Nonflammable

Check Digit Verification of cas no

The CAS Registry Mumber 3962-66-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,6 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3962-66:
(6*3)+(5*9)+(4*6)+(3*2)+(2*6)+(1*6)=111
111 % 10 = 1
So 3962-66-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h14-16H,2-10H2,1H3/t14-,15-,16+,18+/m1/s1

3962-66-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Estr-5(10)-ene-3,17-dione

1.2 Other means of identification

Product number -
Other names 19-Norandrost-5(10)-ene-3,17-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3962-66-1 SDS

3962-66-1Synthetic route

androst-4-ene-3,17-dion-19-oic acid
4757-95-3

androst-4-ene-3,17-dion-19-oic acid

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Conditions
ConditionsYield
With pyridine for 0.5h; Heating;82%
In pyridine at 50℃; for 1h;700 mg
19-oxoandrostenedione
968-49-0

19-oxoandrostenedione

A

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

B

(19S)-3-hydroxy-3β,19-oxido-5β,19-cycloandrostane-17-one

(19S)-3-hydroxy-3β,19-oxido-5β,19-cycloandrostane-17-one

C

(19R)-19-hydroxy-5β,19-cycloandrostane-3,17-dione
160617-57-2

(19R)-19-hydroxy-5β,19-cycloandrostane-3,17-dione

D

(19S)-19-hydroxy-5β,19-cycloandrostane-3,17-dione
160617-58-3

(19S)-19-hydroxy-5β,19-cycloandrostane-3,17-dione

Conditions
ConditionsYield
With acetic acid; zinc for 1.5h; Title compound not separated from byproducts;A 3.3%
B n/a
C 62.5%
D n/a
With acetic acid; zinc for 1.5h;A 3.3%
B n/a
C 62.5%
D n/a
19-oxoandrostenedione
968-49-0

19-oxoandrostenedione

A

17β-hydroxy-estr-5(10)-en-3-one
1089-78-7

17β-hydroxy-estr-5(10)-en-3-one

B

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

C

(19R)-19-hydroxy-5β,19-cycloandrostane-3,17-dione
160617-57-2

(19R)-19-hydroxy-5β,19-cycloandrostane-3,17-dione

D

(19R)-17β,19-dihydroxy-5β,19-cycloandrostan-3-one
192373-63-0

(19R)-17β,19-dihydroxy-5β,19-cycloandrostan-3-one

Conditions
ConditionsYield
With ammonia; lithium In tetrahydrofuran for 0.5h;A 12%
B 11%
C 11%
D 34%
3-methoxyestra-2,5(10)-dien-17-one
17976-32-8

3-methoxyestra-2,5(10)-dien-17-one

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Conditions
ConditionsYield
With methanol; acetic acid
19-hydroxy-4-androstene-3,17-dione
510-64-5

19-hydroxy-4-androstene-3,17-dione

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / pyridinium dichromate / CH2Cl2 / 18 h / 20 °C
2: 3.3 percent / Zn, 50percent aq. AcOH / 1.5 h
View Scheme
Multi-step reaction with 2 steps
1: 7.3 g / Cr2O3, conc. H2SO4 / acetone / 0.5 h / 10 - 15 °C
2: 700 mg / pyridine / 1 h / 50 °C
View Scheme
17,17-ethanediyldioxy-3-methoxy-estra-2,5(10)-diene
1238-30-8

17,17-ethanediyldioxy-3-methoxy-estra-2,5(10)-diene

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Conditions
ConditionsYield
With malonic acid In water; acetone at 20℃; for 4h; Temperature; Reagent/catalyst;
Estrone
53-16-7

Estrone

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: potassium carbonate / N,N-dimethyl-formamide / 16 h / 130 °C
2.1: orthoformic acid triethyl ester; boron trifluoride diethyl etherate / 0.25 h / 25 °C
2.2: 5 h / 25 °C
3.1: ammonia; sodium hydroxide; lithium / tetrahydrofuran / 0.5 h / -78 - -50 °C
3.2: 1 h
4.1: malonic acid / acetone; water / 4 h / 20 °C
View Scheme
estrone 3-methyl ether
1624-62-0

estrone 3-methyl ether

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: orthoformic acid triethyl ester; boron trifluoride diethyl etherate / 0.25 h / 25 °C
1.2: 5 h / 25 °C
2.1: ammonia; sodium hydroxide; lithium / tetrahydrofuran / 0.5 h / -78 - -50 °C
2.2: 1 h
3.1: malonic acid / acetone; water / 4 h / 20 °C
View Scheme
17,17-ethylenedioxy-3-methoxyoestra-1,3,5(10)-triene
28336-29-0

17,17-ethylenedioxy-3-methoxyoestra-1,3,5(10)-triene

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: ammonia; sodium hydroxide; lithium / tetrahydrofuran / 0.5 h / -78 - -50 °C
1.2: 1 h
2.1: malonic acid / acetone; water / 4 h / 20 °C
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

10β-hydroxy-19-norandrost-4-ene-3,17-dione
5189-96-8

10β-hydroxy-19-norandrost-4-ene-3,17-dione

Conditions
ConditionsYield
With copper(II) bis(trifluoromethanesulfonate); triphenylphosphine; N,N,N',N'-tetramethylguanidine In tetrahydrofuran at 20℃; for 17h; regioselective reaction;56%
(i) Na2CrO4, AcOH, (ii) SiO2; Multistep reaction;
Perbenzoic acid
93-59-4

Perbenzoic acid

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

10β-hydroxy-19-norandrost-4-ene-3,17-dione
5189-96-8

10β-hydroxy-19-norandrost-4-ene-3,17-dione

Conditions
ConditionsYield
With benzene
methanol
67-56-1

methanol

estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

3,3-dimethoxyestr-5(10)-en-17-one
19257-34-2

3,3-dimethoxyestr-5(10)-en-17-one

Conditions
ConditionsYield
With malonic acid for 19h;5.1 g
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

ethylene glycol
107-21-1

ethylene glycol

A

3,3-(ethylenedioxy)-5(10)-estren-17-one
6193-99-3

3,3-(ethylenedioxy)-5(10)-estren-17-one

B

estr-5(10)-ene-3,17-dione bis(ethylene ketal)
2220-74-8

estr-5(10)-ene-3,17-dione bis(ethylene ketal)

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene for 2h; Heating;A 586 mg
B 2.55 g
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

ethylene glycol
107-21-1

ethylene glycol

estr-5(10)-ene-3,17-dione bis(ethylene ketal)
2220-74-8

estr-5(10)-ene-3,17-dione bis(ethylene ketal)

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene Heating; Yield given;
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

Dimethyl chlorophosphate
813-77-4

Dimethyl chlorophosphate

Phosphoric acid dimethyl ester (8R,9S,13S,14S)-13-methyl-17-oxo-2,6,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
118544-10-8

Phosphoric acid dimethyl ester (8R,9S,13S,14S)-13-methyl-17-oxo-2,6,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With 2,2,6,6-tetramethyl-piperidine; n-butyllithium 1.) hexane, THF, -70 deg C, 15 min, to room temp.; 2.) HMPA, 5 min, room temp.; Yield given. Multistep reaction;
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

3β-Hydroxyestr-5(10)-en-17-one
3461-60-7

3β-Hydroxyestr-5(10)-en-17-one

Conditions
ConditionsYield
(enzymatic reduction);
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

A

C18H24O3

C18H24O3

B

3-keto-5,10β-epoxy-nor-19-methyl androstanone
5190-31-8

3-keto-5,10β-epoxy-nor-19-methyl androstanone

Conditions
ConditionsYield
With dioxyphthalic acid In diethyl ether; chloroform for 2h; Title compound not separated from byproducts;
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

estra-4-ene-3,17-dione
734-32-7

estra-4-ene-3,17-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2.55 g / TsOH / benzene / 2 h / Heating
2: 1.) tBuOK, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, TsOH, 2 h
View Scheme
Multi-step reaction with 2 steps
1: 2.55 g / TsOH / benzene / 2 h / Heating
2: 1.) tBuOK, CHBr3, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, TsOH, 2 h
View Scheme
Multi-step reaction with 5 steps
1: p-TSA / benzene / Heating
2: N-bromosuccinimide, MgO, H2O / dimethylformamide / 2 h / Ambient temperature
3: 71 percent / NaOMe / methanol; tetrahydrofuran / 8 h / 4 °C
4: 71 percent / KHS, 18-crown-6 / ethane-1,2-diol / 2 h / 140 °C
5: 27 percent / p-TSA / acetone / Ambient temperature
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

17β-((tert-Butyldimethylsilyl)oxy)estr-4-en-3-one
139042-19-6

17β-((tert-Butyldimethylsilyl)oxy)estr-4-en-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) aq. NaOH, BTEAC, CHCl3, 2.) TsOH / 1.) room temperature, 16 h, 2.) acetone, 30 min
View Scheme
Multi-step reaction with 3 steps
1: 586 mg / TsOH / benzene / 2 h / Heating
2: 1.) NaBH4, 2.) imidazole / 1.) MeOH, 1 h, 2.) DMF, 50 deg C, 2 h
3: 1.) tBuOK, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, 2 h
View Scheme
Multi-step reaction with 3 steps
1: 586 mg / TsOH / benzene / 2 h / Heating
2: 1.) NaBH4, 2.) imidazole / 1.) MeOH, 1 h, 2.) DMF, 50 deg C, 2 h
3: 1.) tBuOK, CHBr3, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, 2 h
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

19(S)-bromo-9α,19-cyclo-10α-androst-4-ene-3,17-dione

19(S)-bromo-9α,19-cyclo-10α-androst-4-ene-3,17-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2.55 g / TsOH / benzene / 2 h / Heating
2: 1.) tBuOK, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, TsOH, 2 h
View Scheme
Multi-step reaction with 2 steps
1: 2.55 g / TsOH / benzene / 2 h / Heating
2: 1.) tBuOK, CHBr3, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, TsOH, 2 h
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

17β-hydroxy-19,19-dichloro-5α,19-cyclo-10α-androstan-3-one

17β-hydroxy-19,19-dichloro-5α,19-cyclo-10α-androstan-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) aq. NaOH, BTEAC, CHCl3, 2.) TsOH / 1.) room temperature, 16 h, 2.) acetone, 30 min
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

tert-Butyl-((8R,9S,13S,14S,17S)-3,3-dimethoxy-13-methyl-2,3,4,6,7,8,9,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yloxy)-dimethyl-silane
158388-33-1

tert-Butyl-((8R,9S,13S,14S,17S)-3,3-dimethoxy-13-methyl-2,3,4,6,7,8,9,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yloxy)-dimethyl-silane

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

17β-(tert-butyldimethylsiloxy)-3,3-ethylenedioxyestr-5(10)-ene
158388-29-5

17β-(tert-butyldimethylsiloxy)-3,3-ethylenedioxyestr-5(10)-ene

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 586 mg / TsOH / benzene / 2 h / Heating
2: 1.) NaBH4, 2.) imidazole / 1.) MeOH, 1 h, 2.) DMF, 50 deg C, 2 h
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

17β-(tert-butyldimethylsiloxy)-19,19-dibromo-5,19-cyclo-10α-androstan-3-one

17β-(tert-butyldimethylsiloxy)-19,19-dibromo-5,19-cyclo-10α-androstan-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) CTAB, aq. NaOH, 2.) TsOH / 1.) 48 h, 2.) acetone, 1 h
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

17β-(tert-butyldimethylsiloxy)-19(S)-chloro-5α-hydroxy-9α,19-cyclo-10α-androstan-3-one

17β-(tert-butyldimethylsiloxy)-19(S)-chloro-5α-hydroxy-9α,19-cyclo-10α-androstan-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) aq. NaOH, BTEAC, CHCl3, 2.) TsOH / 1.) room temperature, 16 h, 2.) acetone, 30 min
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-9α,19-cyclo-10α-androst-4-en-3-one

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-9α,19-cyclo-10α-androst-4-en-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) CTAB, aq. NaOH, 2.) aq. HCl / 1.) 18 h, 2.) acetone, 30 min
View Scheme
Multi-step reaction with 3 steps
1: 586 mg / TsOH / benzene / 2 h / Heating
2: 1.) NaBH4, 2.) imidazole / 1.) MeOH, 1 h, 2.) DMF, 50 deg C, 2 h
3: 1.) tBuOK, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, 2 h
View Scheme
Multi-step reaction with 3 steps
1: 586 mg / TsOH / benzene / 2 h / Heating
2: 1.) NaBH4, 2.) imidazole / 1.) MeOH, 1 h, 2.) DMF, 50 deg C, 2 h
3: 1.) tBuOK, CHBr3, 2.) TsOH / 1.) Et2O, -30 deg C, 24 h, 2.) acetone, 2 h
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

17β-(tertbutyldimethylsiloxy)-9α-dichloromethylandrost-5(10)-en-3-one

17β-(tertbutyldimethylsiloxy)-9α-dichloromethylandrost-5(10)-en-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) aq. NaOH, BTEAC, CHCl3, 2.) TsOH / 1.) room temperature, 16 h, 2.) acetone, 30 min
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-5β,6β-dibromomethylene-3,3-dimethoxy-9α,19-cyclo-10α-androst-5(10)-ene

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-5β,6β-dibromomethylene-3,3-dimethoxy-9α,19-cyclo-10α-androst-5(10)-ene

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 650 mg / CTAB, aq. NaOH / 18 h / Ambient temperature
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

17β-(tert-butyldimethylsiloxy)-19(S)-chloro-5β,6β-dichloromethylene-3,3-ethylenedioxy-9α,19-cyclo-10α-androstane

17β-(tert-butyldimethylsiloxy)-19(S)-chloro-5β,6β-dichloromethylene-3,3-ethylenedioxy-9α,19-cyclo-10α-androstane

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 586 mg / TsOH / benzene / 2 h / Heating
2: 1.) NaBH4, 2.) imidazole / 1.) MeOH, 1 h, 2.) DMF, 50 deg C, 2 h
3: 41 mg / various solvent(s) / 3.5 h / 120 - 130 °C
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-5β,6β-dibromomethylene-3,3-ethylenedioxy-9α,19-cyclo-10α-androstane

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-5β,6β-dibromomethylene-3,3-ethylenedioxy-9α,19-cyclo-10α-androstane

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 586 mg / TsOH / benzene / 2 h / Heating
2: 1.) NaBH4, 2.) imidazole / 1.) MeOH, 1 h, 2.) DMF, 50 deg C, 2 h
3: 1.) aq. NaOH, CTAB, 2.) TsOH / 1.) 18 h, 2.) acetone
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-5β,6β-dibromomethylene-9α,19-cyclo-10α-androstan-3-one
158388-34-2

19(S)-bromo-17β-(tert-butyldimethylsiloxy)-5β,6β-dibromomethylene-9α,19-cyclo-10α-androstan-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) CTAB, aq. NaOH, 2.) TsOH / 1.) 48 h, 2.) acetone, 1 h
View Scheme
Multi-step reaction with 4 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 1.) CTAB, aq. NaOH, 2.) aq. HCl / 1.) 18 h, 2.) acetone, 30 min
View Scheme
Multi-step reaction with 5 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
3: 1.7 g / imidazole / dimethylformamide / 1 h / 50 °C
4: 650 mg / CTAB, aq. NaOH / 18 h / Ambient temperature
5: 200 mg / aq. HCl / acetone / 0.5 h / Ambient temperature
View Scheme
estra-5(10)-en-3,17-dione
3962-66-1

estra-5(10)-en-3,17-dione

3,3-dimethoxyestr-5(10)-en-17β-ol
56016-36-5

3,3-dimethoxyestr-5(10)-en-17β-ol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 5.1 g / malonic acid / 19 h
2: 5.2 g / NaBH4 / methanol / 1 h
View Scheme

3962-66-1Relevant academic research and scientific papers

Preparation 19-nor -5 (10)-androstene ketone compound method

-

, (2017/01/12)

The invention discloses a method for preparing a 19-Norandrost-5(10)-ene-3,17-dione compound. The method comprises the steps of by taking estrone as an ingredient, firstly sequentially performing etherification reaction, ketal protection reaction and birch reduction reaction to obtain a birch reduction product; then by taking lower fatty acid as a catalyst, performing selective hydrolysis reaction on the birch reduction product to produce the 19-Norandrost-5(10)-ene-3,17-dione compound. According to the method, the hydrolysis technology of the birch reduction product containing 17-bit ketal protecting group is optimized and improved, and the single 19-Norandrost-5(10)-ene-3,17-dione with high yield and high selectivity can be obtained through selective hydrolysis reaction by taking binary fatty acid as an acid catalyst for the first time; in addition, the fact that the 17-bit ketal protecting derivatives of the single 19-Norandrost-5(10)-ene-3,17-dione compound can be obtained by taking lower unitary fatty acid as a catalyst is found for the first time.

19-hydroxy-5β,19-cyclosteroids: Synthesis, isomerization and ring opening

Templeton, John F.,Ling, Yangzhi,Lin, Weiyang,Majgier-Baranowska, Helena,Marat, Kirk

, p. 1895 - 1904 (2007/10/03)

19(R/S)-Hydroxy-5β,19-cyclosteroids have been synthesised from the 19-formyl 4-en-3-one by reductive cyclization with zinc in aqueous acetic acid. Treatment of the aldehyde with lithium in liquid ammonia also gave the 19(R)-hydroxy-5β,19-cyclosteroid together with the 17β-hydroxy analogue. The 19(R)-alcohol is isomerized to the 19(S)-alcohol in either dilute acidic or basic media via the 3-hydroxy-3,5-cyclosteroid. The 19(S)-alcohol is in equilibrium with its 3-hemiketal. Treatment of the 19(R)-alcohol with methanolic HCl gave the 19(R)- and 19(S)-methyl ethers, the 3-methyl ether 19-ketal and the 3α-methoxy-3β,5β-cyclosteroid. Further rearrangements of the 19(R)- and 19(S)-alcohols take place on more vigorous treatment with acid or base to give cyclopropanol ring-opened aldehydes including a 5β-methyl-A-norsteroid. Metal hydride reduction of the 3-ketone in the 19(R)-alcohol gave only the 3β-alcohol whereas the 19(S)-alcohol gave both the 3α- and 3β-alcohols. Acid treatment of the 3β-alcohols gave products with retention of configuration at C-5 and C-19 while base-catalysed ring opening gave inversion at C-5. Ring opening mainly involved breaking of the 5,19-bond, however, the 19(S)-alcohol also resulted in 10,19-bond cleavage. Structures were established by NMR measurements.

Novel Insertion, Rearrangement and Addition Products from Dihalogenocarbene Reactions with 5(10)-Unsaturated Steroids

Templeton, John F.,Ling, Yangzhi,Lin, Weiyang,Pitura, Randy J.,Marat, Kirk,Bridson, John N.

, p. 1149 - 1158 (2007/10/02)

Novel insertion, rearrangement and addition products from dibromocarbene and dichlorocarbene reactions with 5(10)-unsaturated steroids have been identified.The dihalogenocarbenes were prepared under phase-transfer conditions (CHBr3- or CHCl3-NaOH), and from CHBr3-KOBut-Et2O, phenyl(trichloromethyl)mercury and sodium trichloroacetate.Evidence that the major products arise from an initial dihalogenocarbene reaction on the α face of the molecule is reported.The major products obtained from addition of CBr2 to 3,17-disubstituted estr-5(10)-enes, after ketal hydrolysis, were 19(S)-bromo-9α,19-cyclo-10α-androst-4-en-3-one and 3',3',19(S)-tribromo-3'H-9α,19-cyclopropa-5β,10α-androstan-3-one derivatives together with the 19,19-dibromo-5α,19-cyclo-10α-steroid adduct.No products from addition of CBr2 to the β-face of the double bond, as previously reported, were identified.Reactions of CCl2 gave, besides rearrangement products analogous to those obtained from CBr2, a 5α-hydroxy-9α,19α-cycloandrostane derivative, the 9α-CHCl2 insertion derivative and both α- and β-face addition products to the double bond.Structures were established by homonuclear and heteronuclear correlation and nuclear Overhauser effect NMR measurements and X-ray crystallography.

Biosynthesis of Estrogens. Estr-5(10)-ene-3,17-dione: Isolation, Metabolism and Mechanistic Implications

Ranjith, H.,Dharmaratne, W.,Kilgore, James L.,Roitman, Esther,Shackleton, Cedric,Caspi, Eliahu

, p. 1529 - 1536 (2007/10/02)

The 16-2H2 title compound 5b constituted a significant amount of the non-aromatic metabolites recovered from incubations of 3,17-dioxo-2H3>androst-4-en-19-al 1 with placental aromatase.For the evaluation of the role of compound 5b in the elaboration of estrogens, its transformations at pH 6.5 and 7.2 in the presence and absence of microsomal placental aromatase were investigated.In the presence of the aromatase at pH 6.5, estrogens (6.8percent), products of isomerization of the double bond (Δ5(10) -> Δ4) and products of reduction of the carbonyl groups were formed.When the incubation was carried out at pH 7.2, products similar to those obtained above were isolated but in different yields.Noticeably more estrogens (22.7percent) and less of the reduced products were formed.Additionally, at pH 7.2, 10β-hydroxy-2H2>estr-4-ene-3,17-dione 4a was obtained.In the absence of the aromatase, which was replaced with bovine albumin at both pH 6.5 and 7.2, 2H2>estr-4-ene-3,17-dione 3a and its 10β-hydroxy derivative 4a were formed in large amounts and were the only products detected.The ramifications of our observations in the context of estrogen biosynthesis are discussed.

Suicide inhibitors of aromatase

-

, (2008/06/13)

Thiol-substituted synthetic steriod hormones or androgens having a testosterone ring system backbone are used to inhibit aromatase''s catalyzed conversion of C 19 androgens having a A 4,3-ketone group to estrogens in the treatment of estrogen-dependent tumors, such as metastatic breast cancer in postmenopausal females.The compounds have the general formula: STR1 wherein R 1 =a thiol, such as --SH or --CH 2 SH, and R 2 =OH or =O. The preferred synthetic hormones are 17β-hydroxy-10β-mercaptoestr-4-en-3-one, 19-mercaptoandrost-4-en-3,17-dione, and 10β-mercaptoandrost-4-en-3,17-dione.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3962-66-1